Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
12/2010
12/15/2010CN101918389A Inhibitors of histone deacetylase
12/15/2010CN101918381A Substituted benzoazole PDE4 inhibitors for treating pulmonary and cardiovascular disorders
12/15/2010CN101918380A Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/15/2010CN101918363A Phenyl acetamide derivative
12/15/2010CN101918360A Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
12/15/2010CN101914107A Process for producing thiazole derivative
12/14/2010US7851636 {2-[3-Cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial; antidiabetic agents
12/09/2010WO2010084499A9 Bicyclic heterocyclic spiro compounds
12/09/2010US20100311966 Imidazole carbonyl compound
12/09/2010US20100311766 Antibacterial compositions
12/09/2010US20100311748 Heterocyclic amides useful for the treatment of cancer and psoriasis
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/08/2010EP2258705A1 Pharmaceutically acceptable salts of anti-infective quinolone compound
12/08/2010EP2258704A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP1933835B1 Tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides as lfa-1 inhibitors
12/08/2010CN1960995B Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
12/08/2010CN101910184A Solubilized thiazolopyridines
12/08/2010CN101910177A Macrocyclic indoles as hepatitis c virus inhibitors
12/08/2010CN101910143A Condensed aminodihydrothiazine derivative
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101910138A Herbicidal compounds
12/07/2010US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
12/02/2010WO2010138673A1 Inhibitors of c-met protein kinase
12/02/2010WO2010138665A1 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
12/02/2010WO2010138663A1 Substituted pyrazole inhibitors of c-met protein kinase
12/02/2010WO2010138589A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010138576A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138575A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010136491A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010US20100305156 Inhibitors of c-met protein kinase
12/02/2010US20100305155 Substituted pyrazole inhibitors of c-met protein kinase
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305110 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100301314 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element
12/02/2010CA2772371A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010CA2763631A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763624A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2762479A1 Inhibitors of c-met protein kinase
12/02/2010CA2762190A1 Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
12/02/2010CA2762186A1 Substituted pyrazole inhibitors of c-met protein kinase
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010CN101899058A Method for preparing thiazolopyrimidine compound and application thereof
12/01/2010CN101193898B Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives
12/01/2010CN101193897B Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
11/2010
11/30/2010US7842809 Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
11/30/2010US7842802 Vinorelbine derivatives
11/30/2010US7842685 Sphingosine-1-phosphate (S1P) receptor modulating agents such as 1-((3-fluoro-4-(5(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)methyl)azetidine-3-carboxylic acid, used for the treatment of autoimmune diseases; side effect reduction
11/25/2010WO2010135751A2 Fluorescent cellular markers
11/25/2010WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010135493A2 Alzheimer's disease imaging agents
11/25/2010WO2010135014A1 Tri-cyclic pyrazolopyridine kinase inhibitors
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010US20100298318 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298141 Substituted pyridine n-oxide herbicides
11/25/2010US20100297097 Compounds
11/25/2010CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010CA2753560A1 Inhibitors of phosphatidylinositol 3-kinase
11/24/2010EP2253630A1 Heterocyclic compound and use thereof
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252619A1 Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor) activity
11/24/2010EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/23/2010US7838681 Synthesis of substituted heterocyclic compounds
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838517 Compounds useful as protein kinase inhibitors
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010132520A1 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
11/18/2010WO2010131663A1 Oxamide derivative
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131146A1 Cyclobutenedione derivatives
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010045251A3 Spiro-oxindole compounds and their use as therapeutic agents
11/18/2010US20100292232 Non-nucleoside reverse transcriptase inhibitors
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292206 Heterocyclic compound
11/18/2010US20100292188 Compounds Comprising A Cyclobutoxy Group
11/18/2010CA2761881A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/17/2010EP2251343A1 Imidazothiazoles as p38-kinase-inhibitors
11/17/2010EP2250171A2 Antibacterial fluoroquinolone analogs
11/17/2010CN1863784B 2-naphthylimino-1,3-thiazine derivative
11/16/2010US7834180 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
11/16/2010US7834008 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
11/11/2010US20100285087 Single phenothiazine enantiomers as agents for the prevention of bone loss
11/10/2010EP2247601A1 Thiazopyrimidinones and uses thereof
11/10/2010EP2247588A2 Fused heterocyclic derivative and use thereof
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP1869056B1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives
11/10/2010CN101880280A Bicyclic pyrimidinones and uses thereof
11/10/2010CN101289455B Anti-influenza virus precursor drug and uses thereof
11/09/2010CA2580152C Preparation of antimicrobial formulations using 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010103550A3 Process for the preparation of a thieno [3, 2-e] -1, 2-thiazine-l, 1-dioxide derivative
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 152